Evidence map›Paper›PMID 23608488›Full record

ArticleExperimental cell research2013

IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).

Mariah Chambers, Garrett Kirkpatrick, Michel Evans, Grzegorz Gorski, Sara Foster, Ruth C Borghaei

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Anti-Wrinkle Effect ofAntioxidants (Basel, Switzerland) · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Matrix Metalloproteinases as Regulators of Periodontal Inflammation.International journal of molecular sciences · 2017
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mariah ChambersDepartment of Biochemistry and Molecular Biology, Philadelphia College of Osteopathic Medicine, 4170 City Avenue, Philadelphia, PA 19131, USA.
Garrett Kirkpatrick
Michel Evans
Grzegorz Gorski
Sara Foster
Ruth C Borghaei
Philadelphia College of Osteopathic Medicine · US

Funding

Transcriptional Regulation of Matrix Metalloproteinase-3 (MMP-3)R15DE016277 · NIDCR · PHILADELPHIA COLLEGE OF OSTEOPATHIC MED · PI BORGHAEI, RUTH C · 2004 to 2007
$472k
NIDCR NIH HHS R15 DE016277NIDCR NIH HHS R15DE16277
6 · The paper itself

Abstract

Matrix metalloproteinase-3 (MMP-3) over-expression is associated with tissue destruction in the context of chronic inflammation. Previous studies showed that IL-4 inhibits induction of MMP-3 by IL-1β, and suggested that AP-1 might be involved. Here we show that IL-1 induced binding of transcription factor AP-1 to the MMP-3 promoter consists primarily of c-Jun, JunB, and c-Fos and that binding of c-Jun and c-Fos is inhibited by the combination of cytokines while binding of Jun B is not. Mutation of the AP-1 site in the MMP-3 promoter decreased the ability of IL-4 to inhibit its transcription in transfected MG-63 cells. Western blotting showed that both cytokines activate Jun N-terminal kinase (JNK), but with somewhat different kinetics, and that activation of JNK by both cytokines individually is inhibited by the combination. These results indicate that IL-4 inhibition of MMP-3 expression is associated with reduction of IL-1 induced binding of active forms of the AP-1 dimer, while less active JunB-containing dimers remain, and suggest that these changes are associated with decreased activation of JNK.

Indexed as

Binding SitesBlotting, WesternCell Line, TumorEnzyme ActivationFibroblastsForeskinHumansInterleukin-1Interleukin-4MaleMatrix Metalloproteinase 1Matrix Metalloproteinase 3Mitogen-Activated Protein Kinase 8PeriodontitisPromoter Regions, GeneticProtein BindingFOSB protein, humanInterleukin-1Interleukin-4JunB protein, humanJunD protein, humanMatrix Metalloproteinase 1Matrix Metalloproteinase 3Mitogen-Activated Protein Kinase 8MMP1 protein, humanMMP3 protein, humanProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junRNA, MessengerTranscription Factor AP-1Transcription Factors

Identifiers

PMID23608488
PMCPMC3757497
OpenAlexW1987226130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.